CPT Codes
|
CODE |
DESCRIPTION |
|
85307 |
Activated Protein C (APC) resistance assay |
|
85410 |
alpha-2 antiplasmin (fibrinolytic factors and inhibitors) |
|
0030T |
Antiprothrombin (phospholipid cofactor) antibody, each Ig class |
|
86148 |
Anti-phosphatidylserine (phospholipid) antibody |
|
85300 |
antithrombin III, activity (clotting inhibitors or anticoagulants) |
|
85301 |
antithrombin III, antigen assay (clotting inhibitors or anticoagulants) |
|
86146 |
beta 2 Glycoprotein I antibody, each |
|
86141 |
C-reactive protein; high sensitivity (hsCRP) |
|
86147 |
cardiolipin (phospholipid) antibody, each Ig class |
|
85130 |
Chromogenic substrate assay |
|
85378 |
D-dimer; qualitative or semiquantitative (fibrin degradation products) |
|
85379 |
D-dimer; quantitative (fibrin degradation products) |
|
85380 |
D-dimer; ultrasensitive (eg, for evaluation for venous thromboembolism), qualitative or semiquantitative (fibrin degradation products) |
|
85293 |
high molecular weight kininogen assay (Fitzgerald factor assay) (clotting) |
|
85210 |
factor II, prothrombin, specific (clotting) |
|
85220 |
factor V (AcG or proaccelerin), labile factor (clotting) |
|
85230 |
factor VII (proconvertin, stable factor) (clotting) |
|
85240 |
factor VIII (AHG), one stage (clotting) |
|
85244 |
factor VIII related antigen (clotting) |
|
85245 |
factor VIII, VW factor, ristocetin cofactor (clotting) |
|
85246 |
factor VIII, VW factor antigen (clotting) |
|
85247 |
factor VIII, von Willebrand factor, multimetric analysis (clotting) |
|
85250 |
factor IX (PTC or Christmas) (clotting) |
|
85260 |
factor X (Stuart-Prower) (clotting) |
|
85280 |
factor XII (Hageman) (clotting) |
|
85290 |
factor XIII (fibrin stabilizing) (clotting) |
|
85291 |
factor XIII (fibrin stabilizing), screen solubility (clotting) |
|
85362 |
Fibrin(ogen) degradation (split) products (FDP)(FSP); agglutination slide, semiquantitative |
|
85366 |
Fibrin(ogen) degradation (split) products (FDP)(FSP); paracoagulation |
|
85370 |
Fibrin(ogen) degradation (split) products (FDP)(FSP); quantitative |
|
85384 |
Fibrinogen; activity |
|
85385 |
Fibrinogen; antigen |
|
85520 |
heparin assay |
|
85400 |
plasmin (fibrinolytic factors and inhibitors) |
|
85415 |
plasminogen activator (fibrinolytic factors and inhibitors) |
|
85420 |
plasminogen, except antigenic assay (fibrinolytic factors and inhibitors) |
|
85421 |
plasminogen, antigenic assay (fibrinolytic factors and inhibitors) |
|
85415 |
plasminogen activator (fibrinolytic factors and inhibitors) |
|
85420 |
plasminogen, except antigenic assay (fibrinolytic factors and inhibitors) |
|
85292 |
prekallikrein assay (Fletcher factor assay) (clotting) |
|
85302 |
protein C, antigen (clotting inhibitors or anticoagulants) |
|
85303 |
protein C, activity (clotting inhibitors or anticoagulants) |
|
85305 |
protein S, total (clotting inhibitors or anticoagulants) |
|
85306 |
protein S, free (clotting inhibitors or anticoagulants) |
ABOUT CPT CODES
Current Procedural Terminology (CPT) Codes describe medical procedures performed by physicians and other health providers. The codes were developed by the Health Care Financing Administration (HCFA) (later renamed the Centers for Medicare & Medicaid Services) (CMS) to assist in the assignment of reimbursement amounts to providers by Medicare carriers. A growing number of managed care and other insurance companies, however, base their reimbursements on the values established by HCFA.
Since the early 1970s, HCFA has asked the American Medical Association (AMA) to work with physicians of every specialty to determine appropriate definitions for the codes and to try to determine accurate reimbursement amounts for each code. Two committees within CMS work on these issues: the CPT Committee, which updates the definitions of the codes, and the RUC (Relative Value Update Committee), which recommends reimbursement values to CMS based on data collected by medical societies on the going rate of services described in the codes.
